Azerbaijan National Academy of Sciences

The British-Swedish pharmaceutical company AstraZeneca, registered in the UK, has begun clinical trials of a new drug AZD7442, intended for the prevention and treatment of coronavirus.

The drug is a combination of two antibodies produced by immune cells from one cell clone. Its trial will be attended by 48 UK residents aged 18 to 55 years. The research will track how the new drug affects the body.

medimagazin.com.tr